SCHEMBL5440974

SCHEMBL5440974

ClCCOc1csc2ccccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 3/20 0.46
MAPT P10636 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPK1 P28482 1/20 0.36
KMT2A Q03164 1/20 0.36
CHRNA7 P36544 1/20 0.35
SLC6A4 P31645 2/20 0.35
HDAC3 O15379 1/20 0.34
HDAC4 P56524 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC7 Q8WUI4 1/20 0.34
HDAC2 Q92769 1/20 0.34
HDAC10 Q969S8 1/20 0.34
HDAC11 Q96DB2 1/20 0.34
HDAC8 Q9BY41 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
HDAC9 Q9UKV0 1/20 0.34
HDAC5 Q9UQL6 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4316420 0.82 CYP2A6 (0.52) CYP2A6MAPTSMN1; SMN2MEN1ALDH1A1
SCHEMBL7436689 0.81 CYP2A6 (0.50) CYP2A6MAPTSMN1; SMN2MEN1ALDH1A1
SCHEMBL9386181 0.80 CYP2A6 (0.41) CYP2A6MAPTSMN1; SMN2MEN1ALDH1A1
SCHEMBL6337528 0.78 MEN1 (0.44) CYP2A6MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL12604032 0.74 IDO1 (0.52) MAPTSMN1; SMN2MEN1ALDH1A1MAPK1
SCHEMBL10368172 0.72 ALDH1A1 (0.54) CYP2A6MAPTSMN1; SMN2MEN1ALDH1A1
SCHEMBL13134278 0.71 THRB (0.55) CYP2A6MAPTMEN1ALDH1A1MAPK1
SCHEMBL6848695 0.71 KDM4E (0.54) MAPTSMN1; SMN2ALDH1A1MAPK1
SCHEMBL6597264 0.71 TUBB4A (0.51) CYP2A6MAPTSMN1; SMN2MEN1ALDH1A1
SCHEMBL29968024 0.71 TUBB4A (0.51) CYP2A6MAPTSMN1; SMN2MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8476455-B2 1-N-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them LABORATOIRE THERAMEX (MC) 2013-07-02 US disclosed
US-20070112009-A1 1-N-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them LABORATOIRE THERAMEX (MC) 2007-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112009-A1 1-N-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them H1-0, H1-5, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 CYP2A6 264/4885MAPT 927/4885SMN1; SMN2 3662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.